Sign in
4

Changes in Ownership

ENANTA PHARMACEUTICALS INC Filed Acc 0001062993-23-022051

Sr. VP & CMO sold 534 shares at $9.63 ($5,142)

From the SEC's structured data for this filing

Trades in this filing

Rottinghaus Scott T. · Sr. VP & CMO

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2023-12-05 Sale : show line 1 in the form −534 $9.63 $5,142 26,466 D
Open-market sales · 534 sh · avg $9.63 · $5,142
Loading xslF345X05/form4.xml…